EDITORIAL SYNOPSIS A double blind trial of prednisolone suppositories in out-patients with idiopathic proctitis is reported. Significant improvement was noted. When prednisolone suppositories were given after the patient had already used suppositories of base alone for three weeks the active treatment was no longer so effective.
Local treatment of idiopathic proctitis with suppositories containing corticosteroids was described by Truelove (1959) . He Two comparisons were made: between the drug and control in two groups of patients in an initial three-week period and between the drug and control in two successive three-week periods in the same patient when there was no response to the initial treatment.
SELECTION OF PATIENTS The patients selected for the trial were all out-patients suffering from active idiopathic proctitis as defined by Lennard-Jones et al. (1962) . All experienced rectal bleeding which was not improving spontaneously, and active or moderately active inflammation of the rectal mucosa was seen on sigmoidoscopy. A clear upper limit to the inflammation was visible using ' a 25 cm. Lloyd-Davies sigmoidoscope. Patients were excluded from the trial if there was x-ray evidence of disease involving the colon (in nine patients a barium enema was not performed because of the mild nature of the symptoms). Patients were also excluded from the trial if they had received prednisolone-21-phosphate suppositories during the previous three months.
ALLOCATION OF PATIENTS TO DIFFERENT TREATMENTS At
the first visit each patient selected for the trial was given a prescription as follows: 'Prednisolone-21-phosphate suppository trial, two nightly for three weeks.' Treatments were allocated by the pharmacist in a random order so that the patient received either suppositories consisting of an unmedicated, partially hydrogenated wax or suppositories of the same base each containing prednisolone-21-phosphate, 5 mg. If the symptoms did not improve within three weeks, the patient was told that the treatment would be changed. He was given the alternative suppository and the trial continued for a further three weeks. ASSESSMENT OF RESULTS Symptoms were classified at the end of each treatment as 'no change or worse', 'improved', or 'no symptoms'. Sigmoidoscopic appearances before and after treatment were graded as 'active', 'moderately active', 'inactive', or 'normal', as described by LennardJones, Longmore, Newell, Wilson, and Avery Jones (1960 Figure 1 shows the change in the patient's symptoms and Fig. 2 At the end of three weeks' treatment with prednisolone five out of six patients who had a history of less than one year had no symptoms whereas only four out of 10 patients whose history was longer than one year were free of symptoms at that time. In the control group, three of the four patients with a history of less than one year were unchanged at the end of three weeks. Figures 3 and   4 show the change in symptoms and sigmoidoscopic appearances of 15 patients whose symptoms had not improved during the first three weeks' treatment and who were then given alternative treatment. It will be seen that of the 13 patients now receiving prednisolone, only six improved symptomatically and five sigmoidoscopically. In no case was the disease in complete symptomatic and sigmoidoscopic remission after three weeks' treatment.
DISCUSSION
These results confirm Truelove's (1959) finding that suppositories containing prednisolone-21-phosphate improve the symptoms of most patients with idiopathic proctitis. However, symptomatic and sigmoidoscopic remission within three weeks was complete in only one quarter of the patients in this series. As Truelove (1959) found, prednisolone suppositories are most effective in patients with a history of less than one year, but, in this series, symptomatic and sigmoidoscopic remission was not complete in every case. Table I shows that in this series six of the 16 patients in the prednisolone group and only four of the 23 patients in the control group gave a history of less than one year. It is possible that this distribution weights the trial in favour of the active treatment, though this does not seem likely as results in the control group appear independent of length of history. In addition, among those given the active treatment results were favourable both in those with a long and those with a short history. Surprisingly, most patients who were given prednisolone suppositories as the second treatment after the failure of control suppositories did not improve. This failure suggests that the initial three weeks' treatment with the suppository base alone lessened the chance of a subsequent response to prednisolone.
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